4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000007
Chairperson & CEO sold 9,500 shares at an average $518.03 ($4,921,275)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
21 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $146.03 | $1,387,285 | 9,630 | D |
| 2026-03-09 | Sale : show line 2 in the form 10b5-1 | −200 | $500.05 | $100,010 | 9,430 | D |
| 2026-03-09 | Sale : show line 3 in the form 10b5-1 | −244 | $509.49 | $124,317 | 9,186 | D |
| 2026-03-09 | Sale : show line 4 in the form 10b5-1 | −701 | $510.81 | $358,075 | 8,485 | D |
| 2026-03-09 | Sale : show line 5 in the form 10b5-1 | −896 | $511.73 | $458,514 | 7,589 | D |
| 2026-03-09 | Sale : show line 6 in the form 10b5-1 | −603 | $512.88 | $309,269 | 6,986 | D |
| 2026-03-09 | Sale : show line 7 in the form 10b5-1 | −676 | $513.65 | $347,226 | 6,310 | D |
| 2026-03-09 | Sale : show line 8 in the form 10b5-1 | −565 | $514.90 | $290,919 | 5,745 | D |
| Open-market sales · 9,500 sh · avg $518.03 · $4,921,275 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-09 | Exercise or conversion : show line 22 in the form 10b5-1 Stock Option | −9,500 | 183,000 | D |
Loading xslF345X05/primarydocument.xml…